dapagliflozintorsemidefurosemidesacubitril/valsartansodium-glucose cotransporter-2 inhibitorangiotensin receptor-neprilysin inhibitorHFheart failure (HF)
…wed no significant differences between sacubitril/valsartan and dapagliflozin (win ratio, 1.15; 95% CI 0.71 to 1.88), or between torsemide an…